Low Density Lipoprotein (LDL) Receptor-related Protein 1B Impairs Urokinase Receptor Regeneration on the Cell Surface and Inhibits Cell Migration*

The low density lipoprotein (LDL) receptor-related protein 1B (LRP1B) is a newly identified member of the LDL receptor family and is closely related to LRP. It was discovered as a putative tumor suppressor and is frequently inactivated in lung cancer cells. In the present study, we used an LRP1B minireceptor (mLRP1B4), which mimics the function and trafficking of LRP1B, to explore the roles of LRP1B on the plasminogen activation system. We found that mLRP1B4 and urokinase plasminogen activator receptor (uPAR) form immunoprecipitable complexes on the cell surface in the presence of complexes of uPA and its inhibitor, plasminogen activator inhibitor type-1 (PAI-1). However, compared with cells expressing the analogous LRP minireceptor (mLRP4), cells expressing mLRP1B4 display a substantially slower rate of uPA·PAI-1 complex internalization. Expression of mLRP1B4, or an mLRP4 mutant deficient in endocytosis, leads to an accumulation of uPAR at the cell surface and increased cell-associated uPA and PAI-1 when compared with cells expressing mLRP4. In addition, we found that expression of mLRP1B or the mLRP4 endocytosis mutant impairs the regeneration of unoccupied uPAR on the cell surface and that this correlates with a diminished rate of cell migration. Taken together, these results demonstrate that LRP1B can function as a negative regulator of uPAR regeneration and cell migration.

[1]  A. Jauch,et al.  Alteration of the LRP1B Gene Region Is Associated with High Grade of Urothelial Cancer , 2002, Laboratory Investigation.

[2]  Yonghe Li,et al.  The Putative Tumor Suppressor LRP1B, a Novel Member of the Low Density Lipoprotein (LDL) Receptor Family, Exhibits Both Overlapping and Distinct Properties with the LDL Receptor-related Protein* , 2001, The Journal of Biological Chemistry.

[3]  Yonghe Li,et al.  Differential Functions of Members of the Low Density Lipoprotein Receptor Family Suggested by Their Distinct Endocytosis Rates* , 2001, The Journal of Biological Chemistry.

[4]  R. Czekay,et al.  Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity. , 2001, Molecular biology of the cell.

[5]  Yonghe Li,et al.  Identification of a Major Cyclic AMP-Dependent Protein Kinase A Phosphorylation Site within the Cytoplasmic Tail of the Low-Density Lipoprotein Receptor-Related Protein: Implication for Receptor-Mediated Endocytosis , 2001, Molecular and Cellular Biology.

[6]  M. Kurrer,et al.  Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays. , 2000, Cancer research.

[7]  J. Aguirre-Ghiso,et al.  Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. , 2000, Current opinion in cell biology.

[8]  W. Schneider,et al.  The Reelin Receptor ApoER2 Recruits JNK-interacting Proteins-1 and -2* , 2000, The Journal of Biological Chemistry.

[9]  J. Richardson,et al.  Interactions of the Low Density Lipoprotein Receptor Gene Family with Cytosolic Adaptor and Scaffold Proteins Suggest Diverse Biological Functions in Cellular Communication and Signal Transduction* , 2000, The Journal of Biological Chemistry.

[10]  Yonghe Li,et al.  The YXXL Motif, but Not the Two NPXY Motifs, Serves as the Dominant Endocytosis Signal for Low Density Lipoprotein Receptor-related Protein* , 2000, The Journal of Biological Chemistry.

[11]  E. Blakely,et al.  Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein. , 2000, Cancer research.

[12]  J. Minna,et al.  LRP-DIT, a putative endocytic receptor gene, is frequently inactivated in non-small cell lung cancer cell lines. , 2000, Cancer research.

[13]  F. Blasi.  Proteolysis, Cell Adhesion, Chemotaxis, and Invasiveness Are Regulated by the u-PA-u-PAR-PAI-1 System , 1999, Thrombosis and Haemostasis.

[14]  D. Collen.  The Plasminogen (Fibrinolytic) System , 1999, Thrombosis and Haemostasis.

[15]  B. Binder,et al.  Mechanisms of Signaling through Urokinase Receptor and the Cellular Response , 1999, Thrombosis and Haemostasis.

[16]  Y. Wei,et al.  Role of Urokinase Receptor and Caveolin in Regulation of Integrin Signaling , 1999, Thrombosis and Haemostasis.

[17]  R. Sakthivel,et al.  The Low Density Lipoprotein Receptor-related Protein/α2-Macroglobulin Receptor Regulates Cell Surface Plasminogen Activator Activity on Human Trophoblast Cells* , 1998, The Journal of Biological Chemistry.

[18]  N. Mackman,et al.  Binding of Human Single Chain Urokinase to Chinese Hamster Ovary Cells and Cloning of Hamster u-PAR , 1998, Thrombosis and Haemostasis.

[19]  Yonghe Li,et al.  In vitro Invasiveness of Human Breast Cancer Cells Is Promoted by Low Density Lipoprotein Receptor-Related Protein , 1998, Invasion and Metastasis.

[20]  M. Duffy,et al.  The urokinase‐type plasminogen activator system in cancer metastasis: A review , 1997, International journal of cancer.

[21]  A. Mazar,et al.  Plasminogen activation by pro-urokinase in complex with its receptor--dependence on a tripeptide (Spectrozyme plasmin). , 1997, European journal of biochemistry.

[22]  M. Yamamoto,et al.  Increased expression of low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor in human malignant astrocytomas. , 1997, Cancer research.

[23]  F. Blasi,et al.  Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes , 1997, The EMBO journal.

[24]  M. Stearns,et al.  In situ hybridization studies of α2‐macroglobulin receptor and receptor‐associated protein in human prostate carcinoma , 1996, The Prostate.

[25]  A. Mazar,et al.  Single-chain urokinase-type plasminogen activator bound to its receptor is relatively resistant to plasminogen activator inhibitor type 1. , 1996, Blood.

[26]  U. Weidle,et al.  Decreased expression of both the low-density lipoprotein receptor-related protein/alpha(2)-macroglobulin receptor and its receptor-associated protein in late stages of cutaneous melanocytic tumor progression. , 1996, Cancer research.

[27]  R. Pardi,et al.  alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)- dependent internalization of the urokinase receptor , 1995, The Journal of cell biology.

[28]  H. Geuze,et al.  39 kDa receptor‐associated protein is an ER resident protein and molecular chaperone for LDL receptor‐related protein. , 1995, The EMBO journal.

[29]  F. Blasi,et al.  Protease nexin-1-urokinase complexes are internalized and degraded through a mechanism that requires both urokinase receptor and alpha 2-macroglobulin receptor. , 1994, The Journal of biological chemistry.

[30]  S. Vandenberg,et al.  Expression of α2‐macroglobulin receptor/low density lipoprotein receptor‐related protein is increased in reactive and neoplastic glial cells , 1994, FEBS letters.

[31]  S. Moestrup,et al.  Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. , 1992, The Journal of biological chemistry.

[32]  P. Andreasen,et al.  Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells. , 1990, Cell regulation.

[33]  L. Rosenfeld,et al.  Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells. , 1990, The Journal of biological chemistry.

[34]  Rémy Ricoux,et al.  Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations. , 2002, The American journal of pathology.